FDA Supercharges Oversight: AI Tools Boost Regulatory Data Analysis
The FDA is expanding its AI capabilities with new tools to enhance data analysis and regulatory processes.
The FDA is expanding its AI capabilities with new tools to enhance data analysis and regulatory processes.
Roche's acquisition of PathAI signals a major push towards AI-driven diagnostics in pathology.
The FDA introduces one-day inspectional assessments to enhance its oversight of the medical device industry.
A new index positions China third in global AI competitiveness for life sciences, highlighting its growing prowess in biotech and healthcare AI applications.
A new global index places China third in AI competitiveness for biotechnology and healthcare, highlighting its advancements.